BCBA/UNHD (BCBA/UNHD)

Buenos Aires Stock Exchange: BCBA/UNHD · USD

$13.1

-0.25 (-1.9%)· Recorded snapshot

Market cap	561.8T
Revenue (ttm)	686.3T
Net income (ttm)	24.2T
EPS (ttm)	$817
P/E (trailing)	24.6x
P/E (forward)	18.1x
Dividend	$252 (1.25%)
Volume	1,170

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 686.3T
Net income (ttm): 24.2T
EPS (ttm): $817
P/E (trailing): 24.6x
P/E (forward): 18.1x
Market cap: 561.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E18.1

P25 n/aP50 n/aP75 n/a

Trailing P/E24.6

P25 n/aP50 n/aP75 n/a

ROE15.8

P25 n/aP50 n/aP75 n/a

ROIC12.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/UNHD indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

USD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-13
Employees	390,000
Employees change	-10,000
Employees growth	-2.5%
Enterprise value	$638.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1974
Industry	Healthcare Plans
Is primary listing	No
ISIN number	ARBCOM460390
Last earnings date	2026-10-13
Last refreshed	2026-10-29
Market cap	$561.8T
Next earnings date	2027-01-12
Price	$13.05
Price currency	USD
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	bcba/UNHD
Website	https://www.unitedhealthgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.39x
Average P/E ratio (3Y)	25.01x
Average P/E ratio (5Y)	24.72x
Earnings yield	4.06%
EV/Earnings	26.36x
EV/EBIT	15.76x
EV/EBITDA	13.62x
EV/FCF	18.34x
EV/Sales	0.92x
FCF / EV yield	5.45%
FCF yield	6.2%
Forward P/E	18.14x
Graham number	6.87976
Graham upside	-47.28%
Lynch fair value	$2.81
Lynch upside	-78.44%
P/(FCF - SBC) ratio	16.89x
P/(OCF - SBC) ratio	14.63x
P/B ratio	3.49x
P/E ratio	24.61x
P/FCF ratio	16.14x
P/OCF ratio	14.06x
P/S ratio	0.82x
Price / tangible book value	3.54x
Price/EBITDA ratio	12.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.85%
EBITDA margin	6.42%
Effective tax rate	15.54%
FCF margin	5.02%
Gross margin	20.05%
Operating margin	5.85%
Pretax margin	4.38%
Profit margin	3.53%
Profit per employee	$62.1M
Profitable quarters	9
Profitable years	27
Revenue per employee	$1.8B
ROA	5.24%
ROA (5Y)	6.86%
ROCE	13.38%
ROE	15.77%
ROE (5Y)	20.42%
ROIC	12.39%
ROIC (5Y)	14.86%
SBC / revenue	0.23%
Tax / revenue	0.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-8.96%
EPS growth (Q)	75.93%
EPS growth (QoQ)	-24.56%
EPS growth 10Y	9.96%
EPS growth 3Y	-8.76%
EPS growth 5Y	1.66%
EPS growth quarters	2
EPS growth years	0
FCF growth	31.4%
FCF growth (Q)	-15.65%
FCF growth (QoQ)	-58.41%
FCF growth 3Y	-4.78%
FCF growth 5Y	-0.06%
Net income growth	-9.69%
Net income growth (Q)	75.04%
Net income growth (QoQ)	-25.05%
Net income growth 3Y	-9.86%
Net income growth 5Y	0.59%
Net income growth quarters	1
Net income growth years	0
OCF growth	24.99%
OCF growth (Q)	-13.83%
OCF growth (QoQ)	-53.65%
OCF growth 10Y	5.94%
OCF growth 3Y	-4.13%
OCF growth 5Y	0.76%
Revenue growth	3.42%
Revenue growth (Q)	-0.41%
Revenue growth (QoQ)	0.59%
Revenue growth 10Y	9.54%
Revenue growth 3Y	7.73%
Revenue growth 5Y	10.01%
Revenue growth quarters	126
Revenue growth years	33

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-5.1T
EBIT	$40.2T
EBITDA	$44.1T
EPS	$817.40
Financing cash flow	$-24.5T
Free cash flow	$34.8T
Free cash flow minus SBC	$33.3T
Gross profit	$137.6T
Income taxes	$4.7T
Investing cash flow	$-17.4T
Net borrowing	$-7.4T
Net cash flow	$-2.1T
Net income	$24.2T
Operating cash flow minus SBC	$38.4T
Operating income	$40.2T
Revenue	$686.3T
Stock-based compensation	$1.6T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$176,038.04
Debt / EBITDA	2.44
Debt / equity	0.7
Debt / FCF	3.26
Interest coverage	6.84
Net cash (debt)	$-73.9T
Net cash / market cap	-13.16%
Net debt / EBITDA	1.68
Net debt / equity	0.46
Net debt / FCF	2.12
Piotroski F-Score	6
Shareholders' equity	$160.9T
Tangible book value	$158.8T
Tangible book value per share	$176,038.04
Total assets	$477T
Total cash	$43.5T
Total debt	$113.3T
Total liabilities	$316T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.43
Current ratio	0.74
Net working capital	$-77T
Quick ratio	0.42
Working capital	$-46.1T

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.98%
Dividend growth	5.11%
Dividend growth (3Y)	3.91%
Dividend growth years	1
Dividend payment date	2026-09-22
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$252.39
Dividend yield	1.25%
Ex-dividend date	2026-09-14
Last dividend	$0.05
Payout ratio	51.45%
Shareholder yield	2.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$12.02
1D price change	-1.88%
1M price change	11.2%
1M total return	11.2%
1W price change	-0.6%
1W total return	-0.6%
1Y price change	19.07%
1Y return CAGR	21.32%
1Y total return	21.31%
20-day SMA	$12.49
200-day SMA	$11.37
3M price change	0.3%
3M total return	0.9%
3Y price change	-16.88%
3Y return CAGR	-4.62%
3Y total return	-13.23%
50-day SMA	$12.34
50-day SMA vs 200-day SMA	50over200
52-week high	$14.40
52-week high date	2026-07-16
52-week low	$8.02
52-week low date	2026-03-27
5Y price change	-7.64%
5Y return CAGR	-0.37%
5Y total return	-1.84%
6M price change	19.71%
6M total return	20.86%
All-time high	$19.95
All-time high date	2024-11-12
All-time low	$6.95
All-time low date	2025-08-04
Average true range (ATR)	$0.35
Average volume	3.1K
Change from 52-week high	-9.38%
Change from 52-week low	62.72%
Change from all-time high	-33.33%
Change from all-time low	91.37%
Change from open	-1.06%
Day's gap	-0.83%
Dollar volume	$15,269
High price	$13.38
Low price	$13.01
Monthly RSI	53.52
Open price	$13.19
Position in 52-week range	10.81%
Previous close	$13.30
Price vs 150-day SMA	10.69%
Price vs 20-day SMA	6.48%
Price vs 200-day SMA	16.94%
Price vs 50-day SMA	7.77%
Relative volume	0.38
RSI	64.99
Sharpe ratio	0.67
Sharpe ratio (3Y)	0.04
Sortino ratio	1.09
Sortino ratio (3Y)	0.16
Volume	1.2K
Weekly RSI	62.49
YTD price change	28.13%
YTD total return	30%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	895M
Shares change (QoQ)	-0.44%
Shares change (YoY)	-0.98%
Shares held by insiders	0.17%
Shares held by institutions	88.94%
Short ratio	2.8 days

Deeper analysis on BCBA/UNHD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/UNHD report

Is a complete BCBA/UNHD research report available?

No complete published report is available for bcba/UNHD (BCBA/UNHD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/UNHD (BCBA/UNHD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/UNHD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/UNHD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/UNHD

Frequently asked questions